Filing Details
- Accession Number:
- 0000939767-25-000081
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-16 20:58:03
- Reporting Period:
- 2025-05-15
- Filing Date:
- 2025-05-16
- Accepted Time:
- 2025-05-16 20:58:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 939767 | Exelixis Inc. | EXEL | Biological Products, (No Disgnostic Substances) (2836) | 043257395 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1648367 | J. Christopher Senner | C/O Exelixis, Inc. 1851 Harbor Bay Parkway Alameda CA 94502 | Evp And Cfo | No | Yes | No | No |
Transaction Summary
| Sold: | 100,000 shares | Avg. Price: $46.00 | Total Value: $4,600,000.00 |
| Number of Shares After Transactions: | 967,842 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-05-15 | 41,422 | $44.65 | 967,842 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2025-05-16 | 100,000 | $18.80 | 1,067,842 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-05-16 | 100,000 | $46.00 | 967,842 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option (right to buy) | Disposition | 2025-05-16 | 100,000 | $0.00 | 100,000 | $18.80 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2019-09-10 | 2025-09-09 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 2,723 | Indirect | By 401(k) |
Footnotes
- Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units ("RSUs") awarded on March 4, 2021, March 4, 2022, April 3, 2023, and February 23, 2024.
- Includes 419,440 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of RSUs and performance-based restricted stock units ("PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each PSU represents a contingent right to receive one share of Common Stock.
- Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of May 14, 2025.
- The option, representing the right to purchase a total of 100,000 shares of Common Stock, became fully exercisable on September 10, 2022.
Billionaire Hedge Funds
